Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jan de Jong
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Chemicals & Drugs
Geographic Areas
Phenomena
Procedures
Anatomy
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
21
Rimmelzwaan, Guus
17
Osterhaus, Albert
17
Fouchier, Ron
15
Bartelds, Aad
12
Claas, Eric
11
Osterhaus, A D M E
8
van Der Avoort, Harrie
7
Bestebroer, Theo
6
Osterhaus, AD
5
Rimmelzwaan, GF
5
Beyer, Walter
5
Meijer, Adam
4
Wilbrink, Berry
4
Smith, Derek
3
Palache, Abraham
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jan de Jong (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Russell Colin A; Jones Terry C; Barr Ian G; Cox Nancy J; Garten Rebecca J; Gregory Vicky; Gust Ian D; Hampson Alan W; Hay Alan J; Hurt Aeron C; de Jong Jan C; Kielso Anne; Klimov Alexander I; Kageyama Tsutomu; Komadina Naomi; Lapedes Alan S; Lin Yi P; Mosterin Ana; Obuchi Masatsugu; Odagiri Takato; Osterhaus Albert D M E; Rimmelzwaan Guus F; Shaw Michael W; Skepner Eugene; Stohr Klaus; Tashiro Masato; Fouchier Ron A M; Smith Derek J
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
Vaccine 2008;26 Suppl 4():D31-4.
-
2008: Rimmelzwaan G F; de Jong J C; Donker G A; Meijer A; Fouchier R A M; Osterhaus A D M E
[Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season]
Nederlands tijdschrift voor geneeskunde 2008;152(39):2138-44.
-
2008: de Jong J C
[The practice guideline 'Influenza and influenza vaccination' (first revision) from the Dutch College of General Practitioners; a response from the perspective of virology]
Nederlands tijdschrift voor geneeskunde 2008;152(39):2111-2.
-
2008: Russell Colin A; Jones Terry C; Barr Ian G; Cox Nancy J; Garten Rebecca J; Gregory Vicky; Gust Ian D; Hampson Alan W; Hay Alan J; Hurt Aeron C; de Jong Jan C; Kelso Anne; Klimov Alexander I; Kageyama Tsutomu; Komadina Naomi; Lapedes Alan S; Lin Yi P; Mosterin Ana; Obuchi Masatsugu; Odagiri Takato; Osterhaus Albert D M E; Rimmelzwaan Guus F; Shaw Michael W; Skepner Eugene; Stohr Klaus; Tashiro Masato; Fouchier Ron A M; Smith Derek J
The global circulation of seasonal influenza A (H3N2) viruses.
Science (New York, N.Y.) 2008;320(5874):340-6.
-
2007: de Jong J C; Rimmelzwaan G F; Donker G A; Meijer A; Fouchier R A M; Osterhaus A D M E
[The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season]
Nederlands tijdschrift voor geneeskunde 2007;151(39):2158-65.
-
2007: de Jong J C
[Influenza vaccination in health-care workers: an effective method to reduce the consequences of influenza in health care users]
Nederlands tijdschrift voor geneeskunde 2007;151(39):2143-6.
-
2007: de Jong J C
[New target populations for influenza vaccination; recommendations of the Health Council of the Netherlands]
Nederlands tijdschrift voor geneeskunde 2007;151(39):2140-2.
-
2007: de Jong J C; Smith D J; Lapedes A S; Donatelli I; Campitelli L; Barigazzi G; Van Reeth K; Jones T C; Rimmelzwaan G F; Osterhaus A D M E; Fouchier R A M
Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
Journal of virology 2007;81(8):4315-22.
-
2006: Rimmelzwaan G F; de Jong J C; Donker G A; Meijer A; Fouchier R A M; Osterhaus A D M E
[The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season]
Nederlands tijdschrift voor geneeskunde 2006;150(40):2209-14.
-
2006: de Jong Jan C; Niesters Hubert G; van Doornum Gerard J J
Circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.
Journal of clinical microbiology 2006;44(9):3468.
-
2005: de Jong J C; Rimmelzwaan G F; Bartelds A I M; Meijer A; Fouchier R A M; Osterhaus A D M E
[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06]
Nederlands tijdschrift voor geneeskunde 2005;149(42):2355-61.
-
2005: de Jong J C; Osterhaus A D M E
[The threatening influenza pandemic: a national store of oseltamivir is necessary]
Nederlands tijdschrift voor geneeskunde 2005;149(29):1618.
-
2004: Rimmelzwaan G F; de Jong J C; Bartelds A I M; Wilbrink B; Fouchier R A M; Osterhaus A D M E
[The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season]
Nederlands tijdschrift voor geneeskunde 2004;148(40):1984-8.
-
2004: Smith Derek J; Lapedes Alan S; de Jong Jan C; Bestebroer Theo M; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Mapping the antigenic and genetic evolution of influenza virus.
Science (New York, N.Y.) 2004;305(5682):371-6.
-
2004: Fouchier Ron A M; Hartwig Nico G; Bestebroer Theo M; Niemeyer Berend; de Jong Jan C; Simon James H; Osterhaus Albert D M E
A previously undescribed coronavirus associated with respiratory disease in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(16):6212-6.
-
2004: de Jong J C; Beyer W E; Rimmelzwaan G F; Fouchier R A; Osterhaus A D
[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]
Nederlands tijdschrift voor geneeskunde 2004;148(2):73-9.
-
2003: de Jong J C; Rimmelzwaan G F; Bartelds A I; Wilbrink B; Fouchier R A; Osterhaus A D
[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season]
Nederlands tijdschrift voor geneeskunde 2003;147(40):1971-5.
-
2003: de Jong J C; Palache A M; Beyer W E P; Rimmelzwaan G F; Boon A C M; Osterhaus A D M E
Haemagglutination-inhibiting antibody to influenza virus.
Developments in biologicals 2003;115():63-73.
-
2002: Rimmelzwaan G F; de Jong J C; Bartelds A I M; Wilbrink B; Fouchier R A M; Osterhaus A D M E
[The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season]
Nederlands tijdschrift voor geneeskunde 2002;146(39):1846-50.
-
2002: Osterhaus A D M E; de Jong J C; Rimmelzwaan G F; Claas E C J
H5N1 influenza in Hong Kong: virus characterizations.
Vaccine 2002;20 Suppl 2():S82-3.
-
2002: Beyer W E P; Palache A M; de Jong J C; Osterhaus A D M E
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Vaccine 2002;20(9-10):1340-53.
-
2001: de Jong J C; Rimmelzwaan G F; Bartelds A I; Wilbrink B; Fouchier R A; Osterhaus A D
[2000/01 influenza season and the vaccine composition for the season 2001/'02]
Nederlands tijdschrift voor geneeskunde 2001;145(40):1945-50.
-
2001: de Jong J C; Heinen P P; Loeffen W L; van Nieuwstadt A P; Claas E C; Bestebroer T M; Bijlsma K; Verweij C; Osterhaus A D; Rimmelzwaan G F; Fouchier R A; Kimman T G
Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.
Vaccine 2001;19(31):4452-64.
-
2001: Rimmelzwaan G F; de Jong J C; Bestebroer T M; van Loon A M; Claas E C; Fouchier R A; Osterhaus A D
Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands.
Virology 2001;282(2):301-6.
-
2000: Rimmelzwaan G F; de Jong J C; Bartelds A I; Dorigo-Zetsma J W; Fouchier R A; Osterhaus A D
[Influenza season 1999/2000 and vaccine composition for the season 2000/01]
Nederlands tijdschrift voor geneeskunde 2000;144(41):1968-71.
-
2000: De Jong J C; Rimmelzwaan G F; Fouchier R A; Osterhaus A D
Influenza virus: a master of metamorphosis.
The Journal of infection 2000;40(3):218-28.
-
2000: de Jong J C; Beyer W E; Palache A M; Rimmelzwaan G F; Osterhaus A D
Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
Journal of medical virology 2000;61(1):94-9.
-
2000: Meijer A; Dagnelie C F; De Jong J C; De Vries A; Bestebroer T M; Van Loon A M; Bartelds A I; Ossewaarde J M
Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.
European journal of epidemiology 2000;16(12):1099-106.
-
1999: De Jong J C; Wermenbol A G; Verweij-Uijterwaal M W; Slaterus K W; Wertheim-Van Dillen P; Van Doornum G J; Khoo S H; Hierholzer J C
Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively.
Journal of clinical microbiology 1999;37(12):3940-5.
-
1999: Rimmelzwaan G F; de Jong J C; Bartelds A I; Dorigo-Zetsma J W; Fouchier R A; Osterhaus A D
[Influenza season 1998/99; composition of vaccine for 1999/2000]
Nederlands tijdschrift voor geneeskunde 1999;143(40):2015-8.
-
1999: de Jong J C; Rimmelzwaan G F; Fouchier R A; Osterhaus A D
[Influenza pandemics: past and future]
Nederlands tijdschrift voor geneeskunde 1999;143(40):1988-91.
-
1999: Rimmelzwaan G F; Baars M; van Beek R; de Lijster P; de Jong J C; Claas E C; Osterhaus A D
Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
Vaccine 1999;17(20-21):2512-6.
-
1999: Fleming D M; Zambon M; Bartelds A I; de Jong J C
The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.
European journal of epidemiology 1999;15(5):467-73.
-
1999: Rimmelzwaan G F; Claas E C; van Amerongen G; de Jong J C; Osterhaus A D
ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
Vaccine 1999;17(11-12):1355-8.
-
1999: de Jong J C; van Nieuwstadt A P; Kimman T G; Loeffen W L; Bestebroer T M; Bijlsma K; Verweij C; Osterhaus A D; Class E C
Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy.
Vaccine 1999;17(11-12):1321-8.
-
1999: Andeweg A C; Bestebroer T M; Huybreghs M; Kimman T G; de Jong J C
Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay.
Journal of clinical microbiology 1999;37(3):524-30.
-
1998: Claas E C; Bartelds A I; Dorigo-Zetsma J W; Rimmelzwaan G F; de Jong J C; Osterhaus A D
[The influenza season 1997/'98 and the vaccine composition for 1998/'99]
Nederlands tijdschrift voor geneeskunde 1998;142(44):2423-7.
-
1998: Van Doornum G J; De Jong J C
Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method.
Journal of clinical microbiology 1998;36(10):2865-8.
-
1998: de Jong J C; Claas E C; Osterhaus A D
[Influenza A (H5N1) in Hong Kong: Forerunner of a pandemic or just a scientifically interesting phenomenon and a useful exercise in pandemiology?]
Nederlands tijdschrift voor geneeskunde 1998;142(22):1252-6.
-
1998: Claas E C; de Jong J C; van Beek R; Rimmelzwaan G F; Osterhaus A D
Human influenza virus A/HongKong/156/97 (H5N1) infection.
Vaccine 1998;16(9-10):977-8.
-
1998: de Jong J C; Claas E C; Osterhaus A D
[Influenza A(H5N1) in Hong Kong: forerunner of a pandemic or an only scientifically interesting phenomenon and a useful exercise in pandemiology?]
Tijdschrift voor diergeneeskunde 1998;123(9):278-82.
-
1998: Claas E C; Osterhaus A D; van Beek R; De Jong J C; Rimmelzwaan G F; Senne D A; Krauss S; Shortridge K F; Webster R G
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet 1998;351(9101):472-7.
-
1997: Rimmelzwaan G F; de Jong J C; Bartelds A I; Claas E C; van Wijngaarden J K; Osterhaus A D
[Influenza in the 1996/'97 season; vaccine composition for the 1997/'98 season]
Nederlands tijdschrift voor geneeskunde 1997;141(36):1743-7.
-
1996: Claas E C; de Jong J C; Bartelds A I; Rimmelzwaan G F; van Wijngaarden J K; Osterhaus A D
[Influenza in the 1995/'96 season; vaccine composition for the 1996/'97 season]
Nederlands tijdschrift voor geneeskunde 1996;140(41):2047-50.
-
1996: Kidd A H; Jonsson M; Garwicz D; Kajon A E; Wermenbol A G; Verweij M W; De Jong J C
Rapid subgenus identification of human adenovirus isolates by a general PCR.
Journal of clinical microbiology 1996;34(3):622-7.
-
1996: de Jong J C
[Adenoviruses as causative agents in gastroenteritis]
Nederlands tijdschrift voor geneeskunde 1996;140(10):536-41.
-
1995: de Jong J C; Claas E C; Osterhaus A D
Influenza types and patient population.
Lancet 1995;346(8991-8992):1713-4.
-
1995: Claas E C; de Jong J C; Bartelds A I; Rimmelzwaan G F; van Wijngaarden J K; Osterhaus A D
[Influenza in the 1994/95 season; composition of vaccine for the 1995/96 season]
Nederlands tijdschrift voor geneeskunde 1995;139(42):2154-8.
-
1995: Khoo S H; Bailey A S; de Jong J C; Mandal B K
Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology.
The Journal of infectious diseases 1995;172(3):629-37.
-
1995: Claas E C; de Jong J C; Bartelds A I; Bijlsma K; Rothbarth P; de Groot R; Rimmelzwaan G F; Osterhaus A D
Influenza types and patient population.
Lancet 1995;346(8968):180.
-
1994: Wood S R; Sharp I R; de Jong J C; Verweij-Uijterwaal M W
Development and preliminary evaluation of an enzyme immunosorbent assay for the detection of adenovirus type 8.
Journal of medical virology 1994;44(4):348-52.
-
1994: Claas E C; Kawaoka Y; de Jong J C; Masurel N; Webster R G
Infection of children with avian-human reassortant influenza virus from pigs in Europe.
Virology 1994;204(1):453-7.
-
1994: Claas E C; de Jong J C; Bartelds A I; van Wijngaarden J K; Masurel N; Osterhaus A D
[Influenza in the 1993/'94 season; composition of the vaccine for the 1994/'95 season]
Nederlands tijdschrift voor geneeskunde 1994;138(39):1966-9.
-
1994: Schofield K P; Morris D J; Bailey A S; de Jong J C; Corbitt G
Gastroenteritis due to adenovirus type 41 in an adult with chronic lymphocytic leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(2):311-2.
-
1993: de Jong J C; Bijlsma K; Wermenbol A G; Verweij-Uijterwaal M W; van der Avoort H G; Wood D J; Bailey A S; Osterhaus A D
Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes.
Journal of clinical microbiology 1993;31(6):1562-9.
-
1992: de Jong J C; Démazure M; Legrand-Quillien M C; Le Lay G; Colin J; Wermenbol A G; Verweij-Uÿterwaal M W; van der Avoort H G; Chastel C
New developments in the molecular epidemiology of adenovirus 8 keratoconjunctivitis.
Journal of medical virology 1992;38(2):102-7.
-
1991: Schirm J; Manson W L; Schröder F P; Tegzess A M; van der Avoort H G; de Jong J C
[An adenovirus epidemic in patients with kidney transplantation]
Nederlands tijdschrift voor geneeskunde 1991;135(29):1310-4.
-
1989: Wood D J; de Jong J C; Bijlsma K; van der Avoort H G
Development and evaluation of monoclonal antibody-based immune electron microscopy for diagnosis of adenovirus types 40 and 41.
Journal of virological methods 1989;25(3):241-50.
-
1989: Wood D J; Bijlsma K; de Jong J C; Tonkin C
Evaluation of a commercial monoclonal antibody-based enzyme immunoassay for detection of adenovirus types 40 and 41 in stool specimens.
Journal of clinical microbiology 1989;27(6):1155-8.
-
1989: van der Avoort H G; Wermenbol A G; Zomerdijk T P; Kleijne J A; van Asten J A; Jensma P; Osterhaus A D; Kidd A H; de Jong J C
Characterization of fastidious adenovirus types 40 and 41 by DNA restriction enzyme analysis and by neutralizing monoclonal antibodies.
Virus research 1989;12(2):139-57.
-
1988: de Jong J C; Paccaud M F; de Ronde-Verloop F M; Huffels N H; Verwei C; Weijers T F; Bangma P J; van Kregten E; Kerckhaert J A; Wicki F
Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands.
Annales de l'Institut Pasteur. Virology 1988;139(4):429-37.
-
1988: de Jong J C; de Ronde-Verloop F M; Veenendaal-van Herk T M; Weijers T F; Bijlsma K; Osterhaus A D
Antigenic heterogeneity within influenza A (H3N2) virus strains.
Bulletin of the World Health Organization 1988;66(1):47-55.
-
1986: van der Avoort H G; Adrian T; Wigand R; Wermenbol A G; Zomerdijk T P; de Jong J C
Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985.
Journal of clinical microbiology 1986;24(6):1084-8.
-
1986: de Jong J C; de Ronde-Verloop J M; Bangma P J; van Kregten E; Kerckhaert J; Paccaud M F; Wicki F; Wunderli W
Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986.
Lancet 1986;2(8519):1329-30.
-
1985: de Jong J C; Wermenbol A G; Zomerdijk T P; van der Avoort H G
[Return of adenovirus 21 to the Netherlands]
Nederlands tijdschrift voor geneeskunde 1985;129(52):2521-2.
-
1985: de Jong J C; van der Avoort H G; Wigand R; Adrian T
Revival of adenovirus 21 in Netherlands and West Germany.
Lancet 1985;2(8458):776.
-
1985: Ruigrok R W; Krijgsman P C; de Ronde-Verloop F M; de Jong J C
Natural heterogeneity of shape, infectivity and protein composition in an influenza A (H3N2) virus preparation.
Virus research 1985;3(1):69-76.
-
1985: Weijers T F; Osterhaus A D; Beyer W E; van Asten J A; de Ronde-Verloop F M; Bijlsma K; de Jong J C
Analysis of antigenic relationships among influenza virus strains using a taxonomic cluster procedure. Comparison of three kinds of antibody preparations.
Journal of virological methods 1985;10(3):241-50.
-
1984: Osterhaus A D; Weijers T F; Bijlsma K; de Ronde-Verloop F M; van Asten J A; de Jong J C
Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system.
Developments in biological standardization 1984;57():245-50.
-
1984: de Jong J C; Wigand R; Adrian T; Hierholzer J C; Kapsenberg J G; Muzerie C J; Wermenbol A G
Adenovirus 38: a new human adenovirus species of subgenus D.
Intervirology 1984;22(3):164-9.
-
1983: de Jong J C; Wigand R; Kidd A H; Wadell G; Kapsenberg J G; Muzerie C J; Wermenbol A G; Firtzlaff R G
Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.
Journal of medical virology 1983;11(3):215-31.
-
1982: de Jong J C; de Ronde-Verloop F M; Dorpema J W
Testing of the strain identity of influenza vaccines by haemagglutination inhibition.
Journal of biological standardization 1982;10(3):175-83.
-
1981: de Jong J C; Wigand R; Wadell G; Keller D; Muzerie C J; Wermenbol A G; Schaap G J
Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D.
Journal of medical virology 1981;7(2):105-18.
Sign-in to see more